107 related articles for article (PubMed ID: 7266786)
1. Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
Koide T; Matsushita H
Neuropharmacology; 1981 Mar; 20(3):285-92. PubMed ID: 7266786
[No Abstract] [Full Text] [Related]
2. Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).
Koide T; Uyemura K
Neuropharmacology; 1980 Sep; 19(9):871-5. PubMed ID: 7422097
[No Abstract] [Full Text] [Related]
3. Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
Koide T; Uyemura K
Eur J Pharmacol; 1980 Mar; 62(2-3):147-55. PubMed ID: 7379837
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
[TBL] [Abstract][Full Text] [Related]
5. Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor.
Fludzinski P; Evrard DA; Bloomquist WE; Lacefield WB; Pfeifer W; Jones ND; Deeter JB; Cohen ML
J Med Chem; 1987 Sep; 30(9):1535-7. PubMed ID: 3625701
[No Abstract] [Full Text] [Related]
6. Chronic antidepressant treatment and mouse brain 3H-imipramine binding.
Severson JA; Anderson B
J Neurosci Res; 1986; 16(2):429-38. PubMed ID: 3020258
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.
Andronati S; Sava V; Makan S; Kolodeev G
Pharmazie; 1999 Feb; 54(2):99-101. PubMed ID: 10084155
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.
Robertson DW; Bloomquist W; Cohen ML; Reid LR; Schenck K; Wong DT
J Med Chem; 1990 Dec; 33(12):3176-81. PubMed ID: 2258903
[TBL] [Abstract][Full Text] [Related]
9. Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in spontaneously hypertensive and Wistar-Kyoto rats.
Durand M; Aguerre S; Fernandez F; Edno L; Combourieu I; Mormède P; Chaouloff F
Neuropharmacology; 2000 Sep; 39(12):2464-77. PubMed ID: 10974331
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of serotonin 2C receptor mRNA expression by antidepressants possessing the receptor-blocking activity in the rat brain.
Tohda M; Watanabe H
Jpn J Pharmacol; 1998 Dec; 78(4):515-7. PubMed ID: 9920211
[TBL] [Abstract][Full Text] [Related]
11. Brain serotonin receptors and neuropsychiatric disorders.
Enna SJ
Adv Exp Med Biol; 1981; 133():347-57. PubMed ID: 6274171
[No Abstract] [Full Text] [Related]
12. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
13. The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats.
Friedman E; Cooper T; Yocca F
Eur J Pharmacol; 1986 Apr; 123(3):351-6. PubMed ID: 3013651
[TBL] [Abstract][Full Text] [Related]
14. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
Javaid JI; Perel JM; Davis JM
Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
[No Abstract] [Full Text] [Related]
16. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
Ashby CR; Jiang LH; Wang RY
Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
[TBL] [Abstract][Full Text] [Related]
17. An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment.
Koide T; Matsushita H
Life Sci; 1981 Mar; 28(10):1139-45. PubMed ID: 7231043
[No Abstract] [Full Text] [Related]
18. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
Hulihan-Giblin BA; Park YD; Aulakh CS
Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356
[TBL] [Abstract][Full Text] [Related]
19. Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex.
Wong DT; Robertson DW; Reid LR
Eur J Pharmacol; 1989 Jul; 166(1):107-10. PubMed ID: 2806363
[TBL] [Abstract][Full Text] [Related]
20. [The action of some tetrahydroisoquinoline alkaloids on dopamine and serotonin receptors in the rat brain].
Chen SG; Liu GQ; Min ZD
Yao Xue Xue Bao; 1987 May; 22(5):341-6. PubMed ID: 3687458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
